Covid-19 Impact on Global Alternate-site Infusion Therapy Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Alternate-site Infusion Therapy Revenue
1.4 Covid-19 Implications on Market by Type
1.4.1 Global Alternate-site Infusion Therapy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Administer Drug Intravenously
1.4.3 Other Nnon-oral Routes
1.5 Market by Application
1.5.1 Global Alternate-site Infusion Therapy Market Share by Application: 2020 VS 2026
1.5.2 Cancer
1.5.3 Chronic Disease
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Alternate-site Infusion Therapy Industry Impact
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Covid-19 Implications on Global Alternate-site Infusion Therapy Market Perspective (2015-2026)
2.2 Covid-19 Implications on Global Alternate-site Infusion Therapy Growth Trends by Regions
2.2.1 Alternate-site Infusion Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Alternate-site Infusion Therapy Historic Market Share by Regions (2015-2020)
2.2.3 Alternate-site Infusion Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Alternate-site Infusion Therapy Market Growth Strategy
2.3.6 Primary Interviews with Key Alternate-site Infusion Therapy Players (Opinion Leaders)
3 Covid-19 Implications on Competition Landscape by Key Players
3.1 Global Top Alternate-site Infusion Therapy Players by Market Size
3.1.1 Global Top Alternate-site Infusion Therapy Players by Revenue (2015-2020)
3.1.2 Global Alternate-site Infusion Therapy Revenue Market Share by Players (2015-2020)
3.1.3 Global Alternate-site Infusion Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Alternate-site Infusion Therapy Market Concentration Ratio
3.2.1 Global Alternate-site Infusion Therapy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Alternate-site Infusion Therapy Revenue in 2019
3.3 Alternate-site Infusion Therapy Key Players Head office and Area Served
3.4 Key Players Alternate-site Infusion Therapy Product Solution and Service
3.5 Date of Enter into Alternate-site Infusion Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Covid-19 Implications on Market Size by Type (2015-2026)
4.1 Global Alternate-site Infusion Therapy Historic Market Size by Type (2015-2020)
4.2 Global Alternate-site Infusion Therapy Forecasted Market Size by Type (2021-2026)
5 Covid-19 Implications on Market Size by Application (2015-2026)
5.1 Global Alternate-site Infusion Therapy Market Size by Application (2015-2020)
5.2 Global Alternate-site Infusion Therapy Forecasted Market Size by Application (2021-2026)
6 North America Impact of COVID-19
6.1 North America Alternate-site Infusion Therapy Market Size (2015-2020)
6.2 Alternate-site Infusion Therapy Key Players in North America (2019-2020)
6.3 North America Alternate-site Infusion Therapy Market Size by Type (2015-2020)
6.4 North America Alternate-site Infusion Therapy Market Size by Application (2015-2020)
7 Europe Impact of COVID-19
7.1 Europe Alternate-site Infusion Therapy Market Size (2015-2020)
7.2 Alternate-site Infusion Therapy Key Players in Europe (2019-2020)
7.3 Europe Alternate-site Infusion Therapy Market Size by Type (2015-2020)
7.4 Europe Alternate-site Infusion Therapy Market Size by Application (2015-2020)
8 China Impact of COVID-19
8.1 China Alternate-site Infusion Therapy Market Size (2015-2020)
8.2 Alternate-site Infusion Therapy Key Players in China (2019-2020)
8.3 China Alternate-site Infusion Therapy Market Size by Type (2015-2020)
8.4 China Alternate-site Infusion Therapy Market Size by Application (2015-2020)
9 Japan Impact of COVID-19
9.1 Japan Alternate-site Infusion Therapy Market Size (2015-2020)
9.2 Alternate-site Infusion Therapy Key Players in Japan (2019-2020)
9.3 Japan Alternate-site Infusion Therapy Market Size by Type (2015-2020)
9.4 Japan Alternate-site Infusion Therapy Market Size by Application (2015-2020)
10 Southeast Asia Impact of COVID-19
10.1 Southeast Asia Alternate-site Infusion Therapy Market Size (2015-2020)
10.2 Alternate-site Infusion Therapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Alternate-site Infusion Therapy Market Size by Type (2015-2020)
10.4 Southeast Asia Alternate-site Infusion Therapy Market Size by Application (2015-2020)
11 India Impact of COVID-19
11.1 India Alternate-site Infusion Therapy Market Size (2015-2020)
11.2 Alternate-site Infusion Therapy Key Players in India (2019-2020)
11.3 India Alternate-site Infusion Therapy Market Size by Type (2015-2020)
11.4 India Alternate-site Infusion Therapy Market Size by Application (2015-2020)
12 Central & South America Impact of COVID-19
12.1 Central & South America Alternate-site Infusion Therapy Market Size (2015-2020)
12.2 Alternate-site Infusion Therapy Key Players in Central & South America (2019-2020)
12.3 Central & South America Alternate-site Infusion Therapy Market Size by Type (2015-2020)
12.4 Central & South America Alternate-site Infusion Therapy Market Size by Application (2015-2020)
13Key Players Profiles
13.1 Option Care Health
13.1.1 Option Care Health Company Details
13.1.2 Option Care Health Business Overview and Its Total Revenue
13.1.3 Option Care Health Alternate-site Infusion Therapy Introduction
13.1.4 Option Care Health Revenue in Alternate-site Infusion Therapy Business (2015-2020))
13.1.5 Option Care Health Recent Development and Reaction to COVID-19
13.2 Coram CVS
13.2.1 Coram CVS Company Details
13.2.2 Coram CVS Business Overview and Its Total Revenue
13.2.3 Coram CVS Alternate-site Infusion Therapy Introduction
13.2.4 Coram CVS Revenue in Alternate-site Infusion Therapy Business (2015-2020)
13.2.5 Coram CVS Recent Development and Reaction to COVID-19
13.3 UnitedHealth Group
13.3.1 UnitedHealth Group Company Details
13.3.2 UnitedHealth Group Business Overview and Its Total Revenue
13.3.3 UnitedHealth Group Alternate-site Infusion Therapy Introduction
13.3.4 UnitedHealth Group Revenue in Alternate-site Infusion Therapy Business (2015-2020)
13.3.5 UnitedHealth Group Recent Development and Reaction to COVID-19
13.4 HCA Healthcare
13.4.1 HCA Healthcare Company Details
13.4.2 HCA Healthcare Business Overview and Its Total Revenue
13.4.3 HCA Healthcare Alternate-site Infusion Therapy Introduction
13.4.4 HCA Healthcare Revenue in Alternate-site Infusion Therapy Business (2015-2020)
13.4.5 HCA Healthcare Recent Development and Reaction to COVID-19
13.5 McLaren
13.5.1 McLaren Company Details
13.5.2 McLaren Business Overview and Its Total Revenue
13.5.3 McLaren Alternate-site Infusion Therapy Introduction
13.5.4 McLaren Revenue in Alternate-site Infusion Therapy Business (2015-2020)
13.5.5 McLaren Recent Development and Reaction to COVID-19
13.6 CHI Health
13.6.1 CHI Health Company Details
13.6.2 CHI Health Business Overview and Its Total Revenue
13.6.3 CHI Health Alternate-site Infusion Therapy Introduction
13.6.4 CHI Health Revenue in Alternate-site Infusion Therapy Business (2015-2020)
13.6.5 CHI Health Recent Development and Reaction to COVID-19
13.7 Accredo Health
13.7.1 Accredo Health Company Details
13.7.2 Accredo Health Business Overview and Its Total Revenue
13.7.3 Accredo Health Alternate-site Infusion Therapy Introduction
13.7.4 Accredo Health Revenue in Alternate-site Infusion Therapy Business (2015-2020)
13.7.5 Accredo Health Recent Development and Reaction to COVID-19
13.8 PharMerica
13.8.1 PharMerica Company Details
13.8.2 PharMerica Business Overview and Its Total Revenue
13.8.3 PharMerica Alternate-site Infusion Therapy Introduction
13.8.4 PharMerica Revenue in Alternate-site Infusion Therapy Business (2015-2020)
13.8.5 PharMerica Recent Development and Reaction to COVID-19
13.9 Cleveland Clinic
13.9.1 Cleveland Clinic Company Details
13.9.2 Cleveland Clinic Business Overview and Its Total Revenue
13.9.3 Cleveland Clinic Alternate-site Infusion Therapy Introduction
13.9.4 Cleveland Clinic Revenue in Alternate-site Infusion Therapy Business (2015-2020)
13.9.5 Cleveland Clinic Recent Development and Reaction to COVID-19
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of TablesTable 1. Alternate-site Infusion Therapy Key Market Segments
Table 2. Key Players Covered: Ranking by Alternate-site Infusion Therapy Revenue
Table 3. Ranking of Global Top Alternate-site Infusion Therapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Alternate-site Infusion Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Administer Drug Intravenously
Table 6. Key Players of Other Nnon-oral Routes
Table 7. COVID-19 Impact Global Market: (Four Alternate-site Infusion Therapy Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Alternate-site Infusion Therapy Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Alternate-site Infusion Therapy Players to Combat Covid-19 Impact
Table 12. Global Alternate-site Infusion Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Alternate-site Infusion Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Alternate-site Infusion Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Alternate-site Infusion Therapy Market Share by Regions (2015-2020)
Table 16. Global Alternate-site Infusion Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Alternate-site Infusion Therapy Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Alternate-site Infusion Therapy Market Growth Strategy
Table 22. Main Points Interviewed from Key Alternate-site Infusion Therapy Players
Table 23. Global Alternate-site Infusion Therapy Revenue by Players (2015-2020) (Million US$)
Table 24. Global Alternate-site Infusion Therapy Market Share by Players (2015-2020)
Table 25. Global Top Alternate-site Infusion Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alternate-site Infusion Therapy as of 2019)
Table 26. Global Alternate-site Infusion Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Alternate-site Infusion Therapy Product Solution and Service
Table 29. Date of Enter into Alternate-site Infusion Therapy Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Alternate-site Infusion Therapy Market Size by Type (2015-2020) (Million US$)
Table 32. Global Alternate-site Infusion Therapy Market Size Share by Type (2015-2020)
Table 33. Global Alternate-site Infusion Therapy Revenue Market Share by Type (2021-2026)
Table 34. Global Alternate-site Infusion Therapy Market Size Share by Application (2015-2020)
Table 35. Global Alternate-site Infusion Therapy Market Size by Application (2015-2020) (Million US$)
Table 36. Global Alternate-site Infusion Therapy Market Size Share by Application (2021-2026)
Table 37. North America Key Players Alternate-site Infusion Therapy Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Alternate-site Infusion Therapy Market Share (2019-2020)
Table 39. North America Alternate-site Infusion Therapy Market Size by Type (2015-2020) (Million US$)
Table 40. North America Alternate-site Infusion Therapy Market Share by Type (2015-2020)
Table 41. North America Alternate-site Infusion Therapy Market Size by Application (2015-2020) (Million US$)
Table 42. North America Alternate-site Infusion Therapy Market Share by Application (2015-2020)
Table 43. Europe Key Players Alternate-site Infusion Therapy Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Alternate-site Infusion Therapy Market Share (2019-2020)
Table 45. Europe Alternate-site Infusion Therapy Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Alternate-site Infusion Therapy Market Share by Type (2015-2020)
Table 47. Europe Alternate-site Infusion Therapy Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Alternate-site Infusion Therapy Market Share by Application (2015-2020)
Table 49. China Key Players Alternate-site Infusion Therapy Revenue (2019-2020) (Million US$)
Table 50. China Key Players Alternate-site Infusion Therapy Market Share (2019-2020)
Table 51. China Alternate-site Infusion Therapy Market Size by Type (2015-2020) (Million US$)
Table 52. China Alternate-site Infusion Therapy Market Share by Type (2015-2020)
Table 53. China Alternate-site Infusion Therapy Market Size by Application (2015-2020) (Million US$)
Table 54. China Alternate-site Infusion Therapy Market Share by Application (2015-2020)
Table 55. Japan Key Players Alternate-site Infusion Therapy Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Alternate-site Infusion Therapy Market Share (2019-2020)
Table 57. Japan Alternate-site Infusion Therapy Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Alternate-site Infusion Therapy Market Share by Type (2015-2020)
Table 59. Japan Alternate-site Infusion Therapy Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Alternate-site Infusion Therapy Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Alternate-site Infusion Therapy Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Alternate-site Infusion Therapy Market Share (2019-2020)
Table 63. Southeast Asia Alternate-site Infusion Therapy Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Alternate-site Infusion Therapy Market Share by Type (2015-2020)
Table 65. Southeast Asia Alternate-site Infusion Therapy Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Alternate-site Infusion Therapy Market Share by Application (2015-2020)
Table 67. India Key Players Alternate-site Infusion Therapy Revenue (2019-2020) (Million US$)
Table 68. India Key Players Alternate-site Infusion Therapy Market Share (2019-2020)
Table 69. India Alternate-site Infusion Therapy Market Size by Type (2015-2020) (Million US$)
Table 70. India Alternate-site Infusion Therapy Market Share by Type (2015-2020)
Table 71. India Alternate-site Infusion Therapy Market Size by Application (2015-2020) (Million US$)
Table 72. India Alternate-site Infusion Therapy Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Alternate-site Infusion Therapy Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Alternate-site Infusion Therapy Market Share (2019-2020)
Table 75. Central & South America Alternate-site Infusion Therapy Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Alternate-site Infusion Therapy Market Share by Type (2015-2020)
Table 77. Central & South America Alternate-site Infusion Therapy Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Alternate-site Infusion Therapy Market Share by Application (2015-2020)
Table 79. Option Care Health Company Details
Table 80. Option Care Health Business Overview
Table 81. Option Care Health Product
Table 82. Option Care Health Revenue in Alternate-site Infusion Therapy Business (2015-2020) (Million US$)
Table 83. Option Care Health Recent Development
Table 84. Coram CVS Company Details
Table 85. Coram CVS Business Overview
Table 86. Coram CVS Product
Table 87. Coram CVS Revenue in Alternate-site Infusion Therapy Business (2015-2020) (Million US$)
Table 88. Coram CVS Recent Development
Table 89. UnitedHealth Group Company Details
Table 90. UnitedHealth Group Business Overview
Table 91. UnitedHealth Group Product
Table 92. UnitedHealth Group Revenue in Alternate-site Infusion Therapy Business (2015-2020) (Million US$)
Table 93. UnitedHealth Group Recent Development
Table 94. HCA Healthcare Company Details
Table 95. HCA Healthcare Business Overview
Table 96. HCA Healthcare Product
Table 97. HCA Healthcare Revenue in Alternate-site Infusion Therapy Business (2015-2020) (Million US$)
Table 98. HCA Healthcare Recent Development
Table 99. McLaren Company Details
Table 100. McLaren Business Overview
Table 101. McLaren Product
Table 102. McLaren Revenue in Alternate-site Infusion Therapy Business (2015-2020) (Million US$)
Table 103. McLaren Recent Development
Table 104. CHI Health Company Details
Table 105. CHI Health Business Overview
Table 106. CHI Health Product
Table 107. CHI Health Revenue in Alternate-site Infusion Therapy Business (2015-2020) (Million US$)
Table 108. CHI Health Recent Development
Table 109. Accredo Health Company Details
Table 110. Accredo Health Business Overview
Table 111. Accredo Health Product
Table 112. Accredo Health Revenue in Alternate-site Infusion Therapy Business (2015-2020) (Million US$)
Table 113. Accredo Health Recent Development
Table 114. PharMerica Business Overview
Table 115. PharMerica Product
Table 116. PharMerica Company Details
Table 117. PharMerica Revenue in Alternate-site Infusion Therapy Business (2015-2020) (Million US$)
Table 118. PharMerica Recent Development
Table 119. Cleveland Clinic Company Details
Table 120. Cleveland Clinic Business Overview
Table 121. Cleveland Clinic Product
Table 122. Cleveland Clinic Revenue in Alternate-site Infusion Therapy Business (2015-2020) (Million US$)
Table 123. Cleveland Clinic Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Alternate-site Infusion Therapy Market Share by Type: 2020 VS 2026
Figure 2. Administer Drug Intravenously Features
Figure 3. Other Nnon-oral Routes Features
Figure 4. Global Alternate-site Infusion Therapy Market Share by Application: 2020 VS 2026
Figure 5. Cancer Case Studies
Figure 6. Chronic Disease Case Studies
Figure 7. Others Case Studies
Figure 8. Alternate-site Infusion Therapy Report Years Considered
Figure 9. Global Alternate-site Infusion Therapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Alternate-site Infusion Therapy Market Share by Regions: 2020 VS 2026
Figure 11. Global Alternate-site Infusion Therapy Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Alternate-site Infusion Therapy Market Share by Players in 2019
Figure 14. Global Top Alternate-site Infusion Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alternate-site Infusion Therapy as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Alternate-site Infusion Therapy Revenue in 2019
Figure 16. North America Alternate-site Infusion Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Alternate-site Infusion Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Alternate-site Infusion Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Alternate-site Infusion Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Alternate-site Infusion Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Alternate-site Infusion Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Alternate-site Infusion Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Option Care Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Option Care Health Revenue Growth Rate in Alternate-site Infusion Therapy Business (2015-2020)
Figure 25. Coram CVS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Coram CVS Revenue Growth Rate in Alternate-site Infusion Therapy Business (2015-2020)
Figure 27. UnitedHealth Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. UnitedHealth Group Revenue Growth Rate in Alternate-site Infusion Therapy Business (2015-2020)
Figure 29. HCA Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. HCA Healthcare Revenue Growth Rate in Alternate-site Infusion Therapy Business (2015-2020)
Figure 31. McLaren Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. McLaren Revenue Growth Rate in Alternate-site Infusion Therapy Business (2015-2020)
Figure 33. CHI Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. CHI Health Revenue Growth Rate in Alternate-site Infusion Therapy Business (2015-2020)
Figure 35. Accredo Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Accredo Health Revenue Growth Rate in Alternate-site Infusion Therapy Business (2015-2020)
Figure 37. PharMerica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. PharMerica Revenue Growth Rate in Alternate-site Infusion Therapy Business (2015-2020)
Figure 39. Cleveland Clinic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Cleveland Clinic Revenue Growth Rate in Alternate-site Infusion Therapy Business (2015-2020)
Figure 41. Bottom-up and Top-down Approaches for This Report
Figure 42. Data Triangulation
Figure 43. Key Executives Interviewed